Jeremy T. Larsen, MD | oneAMYLOIDOSISvoice

Published: Jul 22, 2019

Tags

Jeremy T. Larsen is a Hematologist-Oncologist at Mayo Clinic Phoenix, Arizona. He completed his graduation in Biology from Creighton University and received his medical degree from Creighton University School of Medicine. Dr. Larsen completed his residency in internal medicine and fellowship in hematology/oncology from Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine.

Dr. Larsen's areas of interest are multiple myeloma, smoldering multiple myeloma, monoclonal gammopathy (mgus), amyloidosis, waldenstrom macroglobulinemia, lymphoma and benign hematology. Currently he is a member of American Society for Blood and Marrow Transplantation and American Society of Hematology.

Representative Publications:

Utilization of Hematopoietic Stem Cell Transplantation for the Treatment of Multiple Myeloma: A Mayo Stratification of Myeloma and Risk-Adapted Therapy (Msmart) Consensus Statement

Treatment With Bortezomib-Based Therapy, Followed by Autologous Stem Cell Transplantation, Improves Outcomes in Light Chain Amyloidosis: A Retrospective Study

Reduction in Plasma Cell Proliferation After Initial Therapy in Newly Diagnosed Multiple Myeloma Measures Treatment Response And Predicts Improved Survival

Serum Free Light Chain Ratio as a Biomarker for High-Risk Smoldering Multiple Myeloma

Evolving Paradigms in the Management of Multiple Myeloma: Novel Agents and Targeted Therapies

First Name

Jeremy

Middle Name

Last Name

Larsen

Address